Advertising Policy

1. Purpose and Principles

IJMHS accepts advertising as a means of supporting its open-access publishing model while maintaining the highest standards of editorial integrity and independence. All advertising must be clearly distinguishable from editorial content and must not influence editorial decisions, peer review, or content.

2. Separation of Advertising and Editorial Content

  • Clear Distinction: All advertising content must be explicitly labeled as "Advertisement," "Sponsored," or "Partner Content" and must be visually distinct from editorial content through borders, shading, or separate sections.

  • No Influence: Advertisers have no input or influence over editorial decisions, article selection, peer review outcomes, or the journal's scientific content. The editorial and advertising departments operate independently.

3. Eligibility and Content Guidelines

IJMHS will consider advertising that is relevant to its audience of healthcare professionals, researchers, and academics. Examples include:

  • Pharmaceutical products (subject to regulatory approval for promotional content)

  • Medical devices, equipment, and software

  • Conference and continuing medical education (CME) announcements

  • Relevant educational programs or courses

  • Professional association memberships

Prohibited Content: Advertising will not be accepted for:

  • Products or services that are illegal or contravene medical ethics

  • Content that is deceptive, misleading, or makes unsubstantiated claims

  • Content that has not received necessary regulatory clearance for promotion

  • Tobacco, firearms, or gambling products

  • Politically partisan content

  • Content that discriminates against any group or individual

4. Review and Approval Process

  • All advertisements are subject to review and approval by the Publisher or designated Advertising Manager.

  • IJMHS reserves the right to reject, cancel, or request modifications to any advertisement at any time.

  • Approval does not imply endorsement by IJMHS, its editors, editorial board, or publisher.

5. Placement and Formats

  • Advertisements may appear on the journal's website, in email alerts/newsletters, and as sponsored banners or inserts.

  • No Adjacency Restrictions: While IJMHS will make reasonable efforts to avoid placing advertisements adjacent to related editorial content, the journal cannot guarantee such separation and assumes no liability for coincidental placement.

6. Data and Privacy

  • Advertisements may use cookies or tracking technologies in compliance with IJMHS's Privacy Policy and applicable data protection laws (e.g., GDPR, HIPAA where applicable).

  • Advertisers may not collect personal data from IJMHS users without explicit, informed consent.

  • IJMHS does not share its author, reviewer, or subscriber lists with advertisers.

7. Financial Transparency

  • Advertising rates are available upon request from the advertising department.

  • Revenue from advertising supports the journal's open-access operations, including potential reduction of Article Processing Charges (APCs) for authors.

  • The journal will disclose its funding sources (including advertising revenue proportion) in its annual transparency report.

8. Complaints and Compliance

  • Complaints regarding advertisements should be directed to ijmhs@induspublishers.com.

  • IJMHS complies with relevant industry standards and local advertising regulations, including those pertaining to pharmaceutical advertising.

  • Advertisers are responsible for ensuring their content complies with all applicable laws and regulations.

9. Policy Updates

IJMHS reserves the right to modify this advertising policy at any time. Current policy will always be available on the journal's website.

For advertising inquiries: ijmhs@induspublishers.com